[
  {
    "ts": "2025-11-17T01:11:50+00:00",
    "headline": "How the Narrative Around Eli Lilly Is Evolving After New Analyst Updates and Drug Developments",
    "summary": "Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This shift underscores renewed optimism about the company's valuation prospects. The upward revision largely reflects analysts’ growing confidence in revenue growth, supported by robust demand for key treatments and steady execution across major franchises. As Wall Street continues to update its outlook in response to new data and market dynamics, readers will want to keep an...",
    "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "29d1cb09-407d-3d79-8d01-63cd5b70f840",
      "content": {
        "id": "29d1cb09-407d-3d79-8d01-63cd5b70f840",
        "contentType": "STORY",
        "title": "How the Narrative Around Eli Lilly Is Evolving After New Analyst Updates and Drug Developments",
        "description": "",
        "summary": "Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This shift underscores renewed optimism about the company's valuation prospects. The upward revision largely reflects analysts’ growing confidence in revenue growth, supported by robust demand for key treatments and steady execution across major franchises. As Wall Street continues to update its outlook in response to new data and market dynamics, readers will want to keep an...",
        "pubDate": "2025-11-17T01:11:50Z",
        "displayTime": "2025-11-17T01:11:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-17T03:14:03+00:00",
    "headline": "BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts",
    "summary": "With significant upside potential, Structure Therapeutics Inc. (NASDAQ:GPCR) secures a spot on our list of the best small-cap biotech stocks to buy according to analysts. On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a $100 price target. The firm cited upcoming ACCESS I and II Phase 2b […]",
    "url": "https://finance.yahoo.com/news/bmo-capital-remains-bullish-structure-031403378.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "73d4e7a8-5a2b-37dc-a0bc-45572dd3ff21",
      "content": {
        "id": "73d4e7a8-5a2b-37dc-a0bc-45572dd3ff21",
        "contentType": "STORY",
        "title": "BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts",
        "description": "",
        "summary": "With significant upside potential, Structure Therapeutics Inc. (NASDAQ:GPCR) secures a spot on our list of the best small-cap biotech stocks to buy according to analysts. On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a $100 price target. The firm cited upcoming ACCESS I and II Phase 2b […]",
        "pubDate": "2025-11-17T03:14:03Z",
        "displayTime": "2025-11-17T03:14:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/941ea46c30e55f81339ccb5cc72fcc8d",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l_2.Y6nbuKJCrNLGGs1AoQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/941ea46c30e55f81339ccb5cc72fcc8d.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0wmI5pqWUbL6cWBpMz7K8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/941ea46c30e55f81339ccb5cc72fcc8d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-remains-bullish-structure-031403378.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-remains-bullish-structure-031403378.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GPCR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-17T10:25:00+00:00",
    "headline": "This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?",
    "summary": "Healthcare stocks have far outperformed the broader market over the past month.",
    "url": "https://www.fool.com/investing/2025/11/17/sector-crushing-broader-market-invest-healthcare/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "b4890694-4ecd-3b3c-92e8-25b546d72515",
      "content": {
        "id": "b4890694-4ecd-3b3c-92e8-25b546d72515",
        "contentType": "STORY",
        "title": "This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?",
        "description": "",
        "summary": "Healthcare stocks have far outperformed the broader market over the past month.",
        "pubDate": "2025-11-17T10:25:00Z",
        "displayTime": "2025-11-17T10:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bf10dbce2a2c1f7ca47aec991fae58af",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Healthcare providers conferring with a patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f85Qn9DU2fYiYj.wGxX0CQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bf10dbce2a2c1f7ca47aec991fae58af.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rcb9ViK1HH7seSnw0swCUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bf10dbce2a2c1f7ca47aec991fae58af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/17/sector-crushing-broader-market-invest-healthcare/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-suddenly-crushing-broader-market-102500831.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]